Zobrazeno 1 - 10
of 598
pro vyhledávání: '"Ulrich Thalheimer"'
Autor:
Aikaterini MANTAKA, Nikolaos GATSELIS, Christos K. TRIANTOS, Ulrich THALHEIMER, Gioacchino LEANDRO, Kalliopi ZACHOU, Christos KONSTANTAKIS, Asterios SAITIS, Konstantinos THOMOPOULOS, Elias A. KOUROUMALIS, George N. DALEKOS, Dimitrios N. SAMONAKIS
Publikováno v:
Minerva Gastroenterology. 69
Autor:
Serena Schippa, Vincenza Di Gregorio, Valerio Iebba, Valerio Giannelli, Ulrich Thalheimer, Michela Giusto, Manuela Merli
Publikováno v:
World journal of gastroenterology. 20(45)
Liver disease is associated with qualitative and quanti- tative changes in the intestinal microbiota. In cirrhotic patients the alteration in gut microbiota is characterized by an overgrowth of potentially pathogenic bacteria (i.e. , gram negative sp
Autor:
Gioacchino Leandro, Patrizia Burra, David Patch, Ulrich Thalheimer, Andrew K. Burroughs, Marco Senzolo, Evangelos Cholongitas
Publikováno v:
Liver International. 29:1189-1193
INTRODUCTION: Bacterial infections have been hypothetized to be a trigger of variceal bleeding in cirrhotic patients and beta-blockers may have a protective effect by decreasing bacterial translocation, reducing portal pressure. The aim of our study
Publikováno v:
Gastroenterology. 133:2029-2036
g onselective blockers have been shown to reduce the risk of variceal hemorrhage in primary and econdary prophylaxis in patients with cirrhosis. Target eduction of hepatovenous pressure gradient after initition of pharmacologic therapy identifies a g
Autor:
Dimitrios Samonakis, Andrew K. Burroughs, M. Mela, Ulrich Thalheimer, P. Manousou, David Patch, George Kalambokis, Amar P. Dhillon, Alberto Quaglia, Christos Triantos, Marco Senzolo, Evangelos Cholongitas
Publikováno v:
Liver Transplantation. 13:1305-1311
Progression of fibrosis following recurrent hepatitis C virus (HCV) infection is frequent after liver transplantation (LT). Histology remains the gold standard to assess fibrosis, but the value of hepatic venous pressure gradient (HVPG) is being expl
Autor:
David Patch, Christos Triantos, Ulrich Thalheimer, Andrew K. Burroughs, R. Stigliano, Dimitrios Samonakis
Publikováno v:
Transplantation. 79:261-268
Antiviral therapy for recurrent hepatitis C after liver transplantation is increasingly used. This systematic review presents both viral and histological response in three areas: pretransplant (5 studies/180 patients), preemptive therapy soon after t
Publikováno v:
Hepatology. 39:286-290
Many of the complications of cirrhosis reflect the presence of portal hypertension, which is commonly expressed as the hepatic venous pressure gradient (HVPG). Baseline and repeat measurements of HVPG have been recommended for the management of patie
Autor:
Ulrich Thalheimer, Italo Vantini, Elena De Maria, Franco Capra, Marchiori L, Massimo Franchini
Publikováno v:
Digestive Diseases and Sciences. 48:809-814
At present two of the most relevant problems of the therapy of HCV-related chronic active hepatitis are the retreatment of nonresponders to interferon-α (IFN-α) and the definition of a prognostic index of response. We treated 44 patients who previo
Autor:
Ulrich Thalheimer, Franco Capra
Publikováno v:
Digestive Diseases and Sciences. 47:945-953
Since the first human liver transplantation, carried out in 1963, the procedure has become routine with an excellent outcome in terms of both quality and length of survival. One of the major challenges facing the transplant community is the shortage
Publikováno v:
European Journal of Internal Medicine. 22:5-7
Portal hypertension (PH) is a severe complication of liver cirrhosis. Measurement of the degree of portal hypertension is usually performed by measuring the hepatic venous pressure gradient (HVPG) which is the difference between the free hepatic veno